| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 43 |
| 1 | METHOTREXATE | 37 |
| 2 | CYCLOPHOSPHAMIDE | 35 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 35 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 35 |
| 5 | DEXAMETHASONE | 35 |
| 6 | DEXAMETHASONE 1.5 MG | 35 |
| 7 | IBUPFROFEN | 32 |
| 8 | IBUPROFEN | 32 |
| 9 | IBUPROFEN 200 MG | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLOXURIDINE | 2 | 0.0116 |
| 1 | INOTUZUMAB OZOGAMICIN | 12 | 0.0040 |
| 2 | SEROTONIN | 1 | 0.0037 |
| 3 | VADADUSTAT | 1 | 0.0033 |
| 4 | CLOFARABINE | 7 | 0.0031 |
| 5 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 1 | 0.0029 |
| 6 | AMISULPRIDE | 15 | 0.0025 |
| 7 | PLATINUM | 1 | 0.0019 |
| 8 | BETHANECHOL CHLORIDE | 1 | 0.0018 |
| 9 | MARAVIROC | 4 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 86 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 58 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 58 |
| 3 | Alkylating Drug [EPC] | 43 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 40 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 39 |
| 6 | Benzodiazepine [EPC] | 38 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 34 |
| 8 | Opioid Agonist [EPC] | 33 |
| 9 | Platinum-based Drug [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 12 | 0.0040 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 16 | 0.0021 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 4 | 0.0017 |
| 3 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 4 | CD33-directed Immunoconjugate [EPC] | 4 | 0.0011 |
| 5 | Histone Deacetylase Inhibitor [EPC] | 3 | 0.0008 |
| 6 | Asparagine-specific Enzyme [EPC] | 10 | 0.0007 |
| 7 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 8 | Actinomycin [EPC] | 1 | 0.0005 |
| 9 | Protease Inhibitor [EPC] | 20 | 0.0004 |